Yield10 Bioscience, Inc.

Yield10 Bioscience, Inc. is a biotechnology company focused on developing innovative agricultural solutions to enhance crop yields and promote sustainability in farming practices. Yield10 Bioscience, Inc. is engaged in developing agricultural biotechnology solutions.

Founded in 1998 and headquartered in Woburn, Massachusetts, US, the company has undergone strategic pivots to focus on genetically modified crops. The CEO is Brad Howell, who has experience in leading biotechnology firms. In its recent funding activities, Yield10 raised USD 25. 00 mn in a PIPE round on August 10, 2023, with investors including Birchview Capital and Oracle Investment Management, Inc.

The total amount raised by the company is USD 25. 00 mn from two deals. Yield10 Bioscience specializes in innovative agricultural biotechnology solutions aimed at enhancing crop yields and environmental sustainability. Their core products include genetically modified Camelina, which is utilized for oil, high-protein meal, and PHA bioplastics.

They also focus on discovering new yield-enhancing traits that are applicable to major food and feed crops. The company's biotechnology leverages big data analytics to identify novel yield traits, targeting markets in North America and Europe, where there is a pressing need for increased agricultural productivity while maintaining environmental standards. Their clientele includes agricultural businesses and food manufacturers seeking to enhance crop genetics and sustainable practices. Yield10's revenue model primarily relies on partnerships and B2B transactions with agricultural growers and food businesses.

The company engages in agreements to provide advanced biotechnology solutions, including proprietary traits and modified crops. These agreements may involve licensing fees or revenue-sharing arrangements based on yield improvements achieved through Yield10’s technologies. Notably, for the year 2023, Yield10 reported a revenue of USD 60. 00 mn, while the EBITDA for 2022 was negative USD 13.

19 mn. The company is developing over 15 novel yield traits, including omega-3 oil traits and PHA traits, aimed at improving crop performance. Yield10 Bioscience plans to expand its product offerings with new agricultural biotechnologies aimed at enhancing crop yields. The company is exploring opportunities to enter new markets, particularly in North America and Europe, aligning with their strategy to meet the agricultural challenges faced in these regions.

The recent funding of USD 25. 00 mn is expected to support these initiatives, including the research and development of new trait technologies and market expansion activities. In August 2023, Yield10 raised USD 3. 10 mn through a public offering, which will further aid in accelerating their growth objectives.